What does a predominance of CD3‑positive T cells with a smaller CD20‑positive B‑cell population in pleural fluid suggest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Predominance of CD3+ T Cells with Smaller CD20+ B-Cell Population in Pleural Fluid

A predominance of CD3-positive T cells with a smaller population of CD20-positive B cells in pleural fluid most commonly suggests a benign reactive process, particularly tuberculous pleuritis, rather than malignancy. This lymphocyte pattern warrants immediate consideration of tuberculosis and should prompt additional testing with pleural fluid adenosine deaminase (ADA) and/or interferon-gamma, along with tissue sampling for culture.

Diagnostic Interpretation

T-Cell Predominance Indicates Benign Etiology

The T-cell predominant pattern (CD3+ > CD20+) is characteristic of reactive lymphocytosis rather than lymphoma or other malignancies. Most benign lymphocyte-rich pleural effusions are predominantly composed of T cells, while most malignant lymphocyte-rich effusions are of B-cell (CD20+) lineage 1.

  • Tuberculous pleural effusion shows marked CD4+ T-cell accumulation with strong T-cell predominance 2
  • Approximately 76% of lymphocyte-rich pleural effusions with T-cell predominance are ultimately diagnosed as reactive/benign 1
  • Only 24% of lymphocyte-rich effusions prove to be lymphoma/leukemia, and these typically show B-cell predominance 1

When CD3/CD20 Analysis Has Limited Value

CD3/CD20 immunostains provide cost-effective diagnostic information in only 0.8% of lymphocyte-rich pleural effusions 1. These stains are most useful when:

  • There is no prior history of lymphoma/leukemia
  • Peripheral blood counts are normal (no lymphocytosis)
  • Cytomorphology shows small lymphocytes without high-grade features
  • Clinical context is unclear

In the vast majority of cases, history, blood counts, and cytomorphology alone allow for appropriate triage without requiring CD3/CD20 staining 1.

Recommended Diagnostic Algorithm

Immediate Next Steps

  1. Assess for tuberculosis (highest priority given T-cell predominance):

    • Order pleural fluid ADA and/or interferon-gamma 3
    • In high-prevalence populations, these tests support diagnosis of tuberculous effusion 3
    • In low-prevalence populations, ADA serves as an exclusion test 3
    • Tissue sampling for culture and sensitivity remains the preferred diagnostic approach for suspected tuberculous pleural effusion 3

  2. Consider autoimmune causes:

    • Order pleural fluid antinuclear antibody (ANA) if lupus pleuritis is suspected 3
    • Review clinical history for systemic autoimmune disease

  3. Evaluate for heart failure if unilateral effusion:

    • Serum NT-proBNP (not pleural fluid) should be considered 3
    • Pleural fluid NT-proBNP is not superior to serum levels 3

When to Pursue Lymphoma Workup

Comprehensive hematopathologic workup is warranted only when:

  • Large cells with high-grade cytomorphologic features are present (mandates lymphoma/leukemia evaluation regardless of CD3/CD20 ratio) 1
  • Known history of lymphoma/leukemia
  • Concurrent peripheral lymphocytosis suggesting small lymphocytic lymphoma
  • Clinical evidence of systemic lymphoproliferative disease

Critical Pitfalls to Avoid

Do Not Over-Interpret CD3/CD20 Ratios

  • T-cell predominance does not rule out malignancy entirely—it simply makes reactive processes far more likely
  • Malignant pleural effusions from solid tumors (lung, breast, etc.) typically show mononuclear cell predominance but are diagnosed by cytology, not lymphocyte immunophenotyping 4
  • CD3/CD20 staining is designed to detect lymphoma, not carcinomatous effusions

Do Not Rely on Biomarkers Alone

  • Multiple conditions may coexist 3
  • Serum biomarkers should not be used in isolation for diagnosis 3
  • Pleural fluid biomarkers should not be used for diagnosing secondary pleural malignancy 3

Do Not Skip Tissue Sampling for Tuberculosis

While pleural fluid ADA/interferon-gamma are helpful, tissue sampling for culture and sensitivity is the preferred option for all patients with suspected tuberculous pleural effusion 3. This provides definitive diagnosis and allows antimicrobial susceptibility testing.

Summary of Action Items

For T-cell predominant pleural effusion:

  1. Order pleural fluid ADA and/or interferon-gamma immediately
  2. Pursue thoracoscopic or image-guided pleural biopsy for tissue culture (strong recommendation) 3
  3. Check serum NT-proBNP if heart failure suspected
  4. Order pleural fluid ANA if lupus suspected
  5. Reserve full lymphoma workup only for cases with high-grade cytomorphology, known lymphoproliferative disease, or peripheral lymphocytosis

Blind (non-image-guided) pleural biopsies should not be conducted 3.

References

Related Questions

In a 49-year-old man with hypertension presenting with right‑sided pleuritic chest pain, dry cough, and a moderate right pleural effusion whose pleural fluid analysis shows an exudative profile (pleural‑to‑serum protein ratio ≈0.66) and low glucose, what is the most likely cause of the pleural effusion?
In a patient with an exudative pleural effusion suspected to be malignant but with pleural fluid glucose of 15 mg/dL, what should be my primary concern?
In a patient with a history of breast cancer who has pleural fluid analysis showing elevated protein, elevated lactate dehydrogenase, high pH, normal glucose, normal amylase, low triglycerides, and a predominance of mononuclear cells, what is the most likely diagnosis and appropriate management?
Given pleural fluid analysis with low amylase, normal glucose, low LDH, low triglycerides, and 94% lymphocytes, what is the most likely diagnosis and what are the recommended next diagnostic and therapeutic steps?
How should the pleural fluid findings of protein 2.8 g/dL, glucose 100 mg/dL, adenosine deaminase (ADA) 9.9 U/L, total leukocyte count 2,300 cells/µL with 31% neutrophils and 69% lymphocytes, and negative cytology be interpreted and what are the recommended next steps?
Can a negative OraQuick oral rapid HIV test performed at least four weeks after exposure be a false‑negative, and what factors such as early testing, antiretroviral (PrEP/PEP/ART) use, or immune suppression might cause it?
After discontinuing clindamycin, how soon does the associated diarrhea typically resolve?
What is the appropriate evaluation and management of constipation in a patient taking lorazepam?
Is endometrial ablation appropriate for a premenopausal woman who is taking tamoxifen?
Which medication should be discontinued in a patient taking Norvasc (amlodipine) 10 mg, hydrochlorothiazide 12.5 mg, and losartan 50 mg daily who has hypotension (BP 88/47 mm Hg)?
How should I explain to a patient the radioactive iodine uptake (RAIU) test and scan for hyperthyroidism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.